SHZ · Financial Statements

Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ) Financial Statements

$2.80 SHZ: 300267.SZ Market Cap $6.68B

Full income statement, balance sheet, and cash flow statement for Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA52.05
FCF Yield—
Quick Ratio1.18
Interest Coverage—
Return 1Y-18.31%
Return 3Y-17.35%
Return 5Y-29.09%

Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ) financials — frequently asked questions

What is 300267.SZ EV/EBITDA?

Hunan Er-Kang Pharmaceutical Co., Ltd's enterprise value to EBITDA (EV/EBITDA) ratio is 52.05.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
300267.SZ Overview 300267.SZ Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.